Evaluating the Stability and Drug Delivery Potential of Nanoengineered Thiol-Based Composite in Physiological Media: Insights from Experimental and Comparative Studies
摘要
Thiol-grafted nanosilica (nSi-Cys) was engineered to sequester arsenic trioxide (ATO) via As–S binding. The composite, prepared by batch adsorption of As(III) onto cysteine-functionalized SiO₂, reached 94% loading (by mass balance) and retained a negative ζ-potential (reported as an indicator of surface charge, not a surrogate for long-term stability). To anticipate in-vivo behavior, uptake, kinetic retention (12–120 h), and 48 h desorption were quantified at 37 °C in five physiologically relevant media (0.1 M HCl, 5% dextrose, distilled water, Ringer’s lactate, normal saline). Uptake was near-quantitative in acidic and low-salt media (Ceq often < LOD) with minimal desorption over 120 h, whereas normal saline showed lower initial uptake (58% at 120 h) and higher release (31%). Spectroscopic, XRD, and electron-microscopy data supported preservation of the As–S linkage and particle morphology in all but the saline condition; the media trend is consistent with electrolyte screening/ion-specific effects but, given co-variation in ionic strength, ion identity, organics, and pH, does not isolate ionic strength as the sole cause. Collectively, the results suggest nSi-Cys/As may be suitable for acid-exposed settings (e.g., oral or tumor-acid environments) while highlighting constraints under saline conditions. More broadly, the study underscores evaluating nanocarriers in realistic ionic matrices when projecting therapeutic performance.